Abstract | BACKGROUND: SUMMARY OF COMMENT: CONCLUSIONS:
Ticlopidine is effective for both primary and secondary stroke prevention. It has a favorable risk/benefit ratio and is a particularly attractive option for patients who are unable to take aspirin.
|
Authors | G W Albers |
Journal | Stroke
(Stroke)
Vol. 23
Issue 6
Pg. 912-6
(Jun 1992)
ISSN: 0039-2499 [Print] United States |
PMID | 1595115
(Publication Type: Journal Article, Review)
|
Chemical References |
- Drug Combinations
- Ticlopidine
|
Topics |
- Cerebrovascular Disorders
(prevention & control)
- Drug Combinations
- Humans
- Risk Factors
- Ticlopidine
(adverse effects, pharmacology, therapeutic use)
- Vascular Diseases
(drug therapy)
|